Double in situ hybridization for simultaneous detection of porcine reproductive and respiratory syndrome virus (PRRSV) and porcine circovirus (PCV)
Theerapol Sirinarumitr, Steven D. Sorden, Igor Morozov, Prem S. Paul Abstract. A double in situ hybridization method for the simultaneous detection of porcine reproductive and respiratory syndrome virus (PRRSV) and porcine circovirus (PCV) genomes in the same tissue section was applied to lung tissues from 9 pigs in which PRRSV and PCV coinfection had been previously demonstrated. Paraffin-embedded tissue sections were simultaneously hybridized with a digoxigenin-labeled antisense RNA probe for PRRSV and a fluorescein-labeled antisense RNA probe for PCV, and hybridization was detected with anti-digoxigenin alkaline phosphatase/fast red and anti-fluorescein peroxidase/diaminobenzidine, respectively. PRRSV and PCV genomes were identified in the same pulmonary cell types as reported previously in all 9 pigs. In all pigs, PCV-positive cells outnumbered PRRSV-positive cells. A small proportion of alveolar macrophages contained both PRRSV and PCV genomes.
Porcine reproductive and respiratory syndrome (PRRS) is characterized by reproductive failure (stillborn, mummified, or weak-born piglets) and interstitial pneumonia in young and growing pigs. 2, 3, 5, 12, 13 PRRS virus (PRRSV) was first isolated in 1991 in The Netherlands 13 and then in 1992 in the United States. 3 Alveolar macrophages in the lung and follicular macrophages and dendritic cells in lymph nodes and tonsil are the major sites of PRRSV replication. 6, 8, 11 Recently, porcine circovirus (PCV) has been isolated from pigs with postweaning multisystemic wasting syndrome (PMWS). 1, 9, 10 PMWS is characterized clinically by emaciation, dyspnea, and lymph node enlargement and pathologically by lymphoid depletion and lymphohistiocytic to granulomatous lymphadenitis, interstitial pneumonia, hepatitis, interstitial nephritis, and pancreatitis. 1, 9, 10 Previous in situ hybridization (ISH) studies have localized the PCV genome predominantly within pulmonary alveolar macrophages and macrophages within lymph nodes, tonsil, spleen, and Peyer's patch; the PCV genome has also been demonstrated within endothelial cells, enterocytes, pancreatic acinar cells, and renal tubular epithelial cells. 1, 10 The majority (60%) of porcine tissue submissions to the Iowa State University Veterinary Diagnostic Laboratory (ISUVDL) in which PCV genome or antigen are detected also contain PRRSV antigen (S.D. Sorden, unpublished data). The purpose of the present study was to develop a double ISH technique for simultaneous detection of both viruses to reduce time, reagents, numbers of slides, and cost for the diagnosis of these 2 viral infections. Because both viruses infect macrophages, another objective of this study was to determine whether these 2 viruses can simultaneously infect the same individual cell.
Formalin-fixed, paraffin-embedded tissues from 9 pigs submitted as separate diagnostic cases to the ISUVDL were studied. Dual infection with PRRSV and PCV had been demonstrated in lung tissue from these pigs by immunohistochemistry and ISH, respectively, as previously described. 8, 10 PRRSV infection was reconfirmed by ISH, as previously described. 7 Negative controls were blocks of lung tissue from 8 cesarean-derived, colostrum-deprived pigs that served as negative controls in previous experiments and that were negative for PRRSV by immunohistochemistry and ISH and negative for PCV by ISH. Tissues from PCV-negative pigs that had been experimentally inoculated with PRRSV and tissues from PCV-infected/PRRSV-negative pigs from clinical cases were used as PRRSV-and PCVpositive controls, respectively.
The RNA probe for PCV was prepared from plasmid pPSP.PCV1 containing 530 bp of open reading frame (ORF) 1 of PCV ISU-31 10 in a pGEM-T a vector, and the RNA probe for PRRSV was prepared from plasmid pPSP.345 containing ORFs 7 and 6 and 50 nucleotides of the 3Ј end of ORF Sections of 5 m thickness were deparaffinized, rehydrated, and treated with proteinase K (50 g/ml) for 10 minutes at 37 C. Sections were washed in diethylpyrocarbonate (DEPC)-treated water and incubated with 3% H 2 O 2 for 5 minutes at room temperature. Sections were then washed in DEPC-treated water for 5 minutes, incubated with 20% cold acetic acid, and washed with DEPC-treated water for 5 minutes. Sections were prehybridized with 200 l of hybridization buffer (50% formamide, 10% dextran sulfate, 3ϫ standard saline citrate [SSC], 50 mM sodium phosphate, pH 7.1, 1ϫ Denhardt's solution, 0.1 mg/ml yeast tRNA, and 10 mM dithiothreitol) using CoverWell chambers c at 95 C for 10 minutes. Sections were hybridized with 50 l of hybridization buffer containing 2 l (1 ng/l) each of fluoresceinlabeled probe for PCV and digoxigenin-labeled probe for PRRSV at 42 C for 16 hours. Sections were treated with 20 g/ml RNase A d at 37 C for 30 minutes and washed in 2ϫ SSC for 5 minutes at 42 C, 1ϫ SSC for 5 minutes at 42 C, and 0.5ϫ SSC for 1 hour at 42 C. Sections were then incubated with blocking solution consisting of 0.5% (w/v) blocking agent c in Tris-buffered saline (TBS; 100 mM Tris HCl, pH 7.5, 400 mM NaCl) at room temperature for 1 hour, washed with TBS for 1 minute, and incubated with antifluorescein peroxidase f (1:60) and anti-digoxigenin alkaline phosphatase f (1:300) at room temperature for 1 hour. Sections were washed in TBS 3 times for 5 minutes each, followed by a 5-minute wash in phosphate-buffered saline (PBS). Sections were incubated with 3,3Ј-diaminobenzidine f for 6 minutes at room temperature, washed in PBS for 5 minutes, and equilibrated in detection buffer for 5 minutes (100 mM Tris HCl, pH 9.5, 100 mM NaCl, 50 mM MgCl 2 ). Slides were incubated with 1 Fast Red tablet f in 10 ml of detection buffer at room temperature for 30 minutes and counterstained with hematoxylin for 1 minute.
Lung sections from all 9 dually infected pigs were positive for both PRRSV and PCV using this double ISH procedure. PRRSV-infected cells were primarily alveolar macrophages and fewer mononuclear cells in alveolar septa. PCV-infected cells were primarily alveolar macrophages, small mononuclear cells consistent with lymphocytes, and fusiform cells around airways. In all 9 pigs, PCV-infected cells greatly outnumbered PRRSV-infected cells. The vast majority of labeled cells were positive for only PRRSV or PCV. However, in 6 of 9 lungs the cytoplasm of a small number (2-5%) of labeled mononuclear cells contained both reaction products (Fig. 1) . Tissues from PRRSV-infected/PCV-negative control pigs were only positive for PRRSV genome, and tissues from PCV-infected/PRRSV-negative control pigs were only positive for PCV. No labeled cells were present in tissues from the 8 negative control pigs.
Although simultaneous demonstration of 2 (or more) agents in a single tissue section has several advantages over sequential detection of agents in serial sections, the primary advantage is the ability to demonstrate colocalization of viral genomes or antigens in a single cell. Serial 5-m sections that contain the same individual cell are difficult to obtain reliably. Although more time consuming than single-agent detection procedures, double ISH or immunohistochemical techniques require fewer sections and reagents than do separate procedures for 2 separate sections. Simultaneous hy-bridization, as described here, also saves time compared with performing immunohistochemistry or ISH for 1 agent followed by ISH for a second agent on the same section; the latter approach generally takes about 3 days instead of the 2 days required for the double ISH technique described here.
This double ISH technique was successful in simultaneously demonstrating PRRSV and PCV genomes in the same tissue section. PRRSV and PCV were identified in the same pulmonary cell types as reported previously. 1, [6] [7] [8] 10, 11 In all pigs, PCV-positive cells outnumbered PRRSV-positive cells. This finding is typical of the PMWS cases submitted to the ISUVDL and has been noted by others using sequential immunohistochemical tests for PCV and PRRSV antigens in serial sections. 4 Both PRRSV and PCV genomes were found in a small proportion of alveolar macrophages (Fig. 1 ). Whether this observation reflects productive coinfection or phagocytosis of debris from necrotic PRRSV-or PCV-infected cells remains to be determined. 
Usefulness of a commercially available enzyme immunoassay for Shiga-like toxins I and II as a presumptive test for the detection of Escherichia coli O157:H7 in cattle feces
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Abstract. The performance of a commercially available enzyme immunoassay (EIA) for determining the presence of Shiga toxin I and II in human diarrheal stool samples was evaluated for use as a presumptive test for the presence of Escherichia coli O157:H7 in nondiarrheal bovine fecal samples collected from 10 Kansas cow-calf ranches. The prevalence of E. coli O157:H7 in 2,297 samples, as determined by selective bacterial culture, was 1.6%. The sample prevalence of non-E. coli O157:H7 Shiga toxin-producing bacteria, as detected by the Shiga toxin EIA, was 5.8%. Only 2 of 136 samples that tested positive with the Shiga toxin EIA were positive for E. coli O157:H7 by culture. Compared with bacterial culture, the sensitivity of the Shiga toxin EIA was 5.5% and the specificity was 94.1%. Agreement between the 2 tests, as measured by the kappa statistic, was poor ( ϭ Ϫ0.002). Although the Shiga toxin EIA was not a good presumptive test for the determination of E. coli O157:H7 in bovine fecal samples because of its low sensitivity (5.5%), it might be a useful test for the detection of Shiga toxin producing non-E. coli O157:H7 organisms in bovine feces.
Shiga toxins I and II produced by Escherichia coli O157: H7 lead to hemorrhagic colitis (HC) and hemolytic uremic syndrome (HUS) in humans. 11, 12, 14 Consumption of undercooked contaminated beef is often the source of human E. coli infection. In the United States between 1982 and 1994, ground beef was responsible for 22 outbreaks of human disease. 4 Cattle shedding E. coli O157:H7 in their feces do so intermittently and show no clinical signs of disease. 5, [7] [8] [9] There is growing need for collecting samples from livestock before slaughter for determining E. coli O157:H7 prevalence and, as part of livestock producer programs such as Hazard analysis critical control point (HACCP), so that efforts can be made to reduce pathogens before the animals are transported to slaughter. O157:H7 can produce either or both Shiga toxins in varying quantities. This EIA targets preformed Shiga toxin but does not identify bacterial species or serotypes. Bacteria in the sample must have produced Shiga toxin when a positive results occurs because the EIA does not detect Shiga toxin genes. Although E. coli O157:H7 is the most frequent (80%) Shiga toxin-producing organism isolated from HC and HUS patients, 6 at least 100 other EHEC serotypes have been associated with these conditions. 3 The prevalence of this organism is low in environmental, live animal, and carcass samples, so many samples must be collected and tested to determine its presence. Thus, the Shiga toxin EIA might be used to narrow the search for a particular Shiga toxin-producing organism. Although the material costs of the Shiga toxin EIA are higher than the material costs for bacterial culture, the labor costs of bacterial culture are considerably higher than the cost of the EIA. The results from the Shiga toxin EIA are available within 1 day instead of 4 days.
Test sensitivity and specificity may differ for samples that originate from nonclinical or clinical cases than from experimentally spike samples that are used to develop the test. Therefore, field samples rather than spiked samples were used to evaluate the Shiga toxin EIA. The purpose of this research was to determine if the Shiga toxin EIA could be used to identify E. coli O157:H7-positive samples of nondiarrheal bovine feces. If the Shiga toxin EIA is both sen-
